{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-023263","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2022-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.453731+00:00","generated_at":"2026-06-23T23:08:59.915973+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biotricity reports Q1 FY2023 revenue $2.1M, net loss $5M, launches Biotres and Bioheart","bullets":["Revenue $2.1M; gross margin 60% consistent with FY22; net loss $5M ($0.098/sh); adjusted loss $0.085/sh.","Launched Biotres wireless holter patch after FDA clearance; also launched Biokit and Bioheart.","Expanded physician network to 29 states with over 2,000 physicians using products."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-023263","json":"https://secwatch.observer/filing/0001493152-22-023263.json","markdown":"https://secwatch.observer/filing/0001493152-22-023263.md","text":"https://secwatch.observer/filing/0001493152-22-023263.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315222023263/0001493152-22-023263-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315222023263/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:08:59.915973+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}